|
Age in years, mean (SD)
| |
84.7 (5.6)
|
85.3 (6.5)
|
0.224
|
|
Gender, n (%)
|
Male
|
5 (21.7)
|
5 (22.7)
|
> 0.999
|
| |
Female
|
18 (78.3)
|
17 (77.3)
|
> 0.999
|
|
MMSE, mean (SD)b
| |
18 (4.4)
|
17 (4.2)
|
0.102
|
|
Diagnosis, n (%)
|
Alzheimer’s disease
|
17 (73.9)
|
14 (63.6)
|
0.530
|
| |
Vascular dementia
|
2 (8.7)
|
4 (18.2)
|
0.414
|
| |
Mixed Alzheimer’s and vascular dementia
|
2 (8.7)
|
3 (13.6)
|
0.665
|
| |
Frontotemporal Degeneration
|
0 (0)
|
1 (4.5)
|
0.489
|
| |
Lewy body disease
|
0 (0)
|
0 (0)
|
> 0.999
|
| |
Neurocognitive disorder not otherwise specified
|
2 (8.7)
|
0 (0)
|
0.489
|
|
Somatic comorbidities, n (%)
|
Diabetes type II
|
2 (8.7)
|
5 (22.7)
|
0.243
|
| |
Heart disease
|
8 (34.8)
|
11 (50.0)
|
0.375
|
| |
Hypertension
|
4 (17.4)
|
0 (0)
|
0.109
|
| |
Gait disorders
|
12 (52.2)
|
14 (63.6)
|
0.550
|
| |
Visual deficiencies (cataract, glaucoma)
|
3 (13.0)
|
0 (0)
|
0.233
|
|
Indoor mobility, n (%)
|
Wheelchair
|
2 (8.7)
|
0 (0)
|
0.49
|
| |
4-wheeled walker
|
3 (13.0)
|
4 (18.2)
|
0.70
|
| |
Single-point walking cane
|
0 (0)
|
2 (9.1)
|
0.23
|
| |
No walking aid
|
18 (78.3)
|
16 (72.7)
|
0.74
|
|
Attendance rates (%)
| |
82.9
|
73.7
|
0.07
|
